 | Up a level |
Martinello, Marianne; Carson, Joanne M; Van Der Valk, Marc; Rockstroh, Jürgen K; Ingiliz, Patrick; Hellard, Margaret; Nelson, Mark; Lutz, Thomas; Bhagani, Sanjay; Kim, Arthur Y; Hull, Mark; Cordes, Christiane; Moon, Juhi; Feld, Jordan J; Gane, Ed; Rauch, Andri; Bruneau, Julie; Tu, Elise; Applegate, Tanya; Grebely, Jason; ... (2023). Reinfection incidence and risk among people treated for recent hepatitis C virus infection: the react study. AIDS, 37(12), pp. 1883-1890. Wolters Kluwer Health 10.1097/QAD.0000000000003651
Carson, Joanne M; Barbieri, Sebastiano; Cunningham, Evan; Mao, Eric; van der Valk, Marc; Rockstroh, Jürgen K; Hellard, Margaret; Kim, Arthur; Bhagani, Sanjay; Feld, Jordan J; Gane, Ed; Thurnheer, Maria C; Bruneau, Julie; Tu, Elise; Dore, Gregory J; Matthews, Gail V; Martinello, Marianne (2023). Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study. Journal of the International AIDS Society, 26(9), e26168. BioMed Central 10.1002/jia2.26168
Matthews, Gail V; Bhagani, Sanjay; Van der Valk, Marc; Rockstroh, Juergen; Feld, Jordan J; Rauch, Andri; Thurnheer, Christine; Bruneau, Julie; Kim, Arthur; Hellard, Margaret; Shaw, David; Gane, Ed; Nelson, Mark; Ingiliz, Patrick; Applegate, Tanya L; Grebely, Jason; Marks, Phillipa; Martinello, Marianne; Petoumenos, Kathy; Dore, Gregory J; ... (2021). Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection. Journal of hepatology, 75(4), pp. 829-839. Elsevier 10.1016/j.jhep.2021.04.056
Grebely, Jason; Dalgard, Olav; Conway, Brian; Cunningham, Evan B; Bruggmann, Philip; Hajarizadeh, Behzad; Amin, Janaki; Bruneau, Julie; Hellard, Margaret; Litwin, Alain H; Marks, Philippa; Quiene, Sophie; Siriragavan, Sharmila; Applegate, Tanya L; Swan, Tracy; Byrne, Jude; Lacalamita, Melanie; Dunlop, Adrian; Matthews, Gail V; Powis, Jeff; ... (2018). Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial. The lancet. Gastroenterology & hepatology, 3(3), pp. 153-161. Elsevier 10.1016/S2468-1253(17)30404-1
